Top Abstract Purchase Related
Home
>
Node
>
Subnode

New therapeutic approach to pancreatic cancer by monoclonal antibodies

Sawada, T.; Chung, Y.S.; Sowa, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1654-1656

1996

ISSN/ISBN: 0385-0684
PMID: 8886037
Document Number: 460358
The prognosis of pancreatic cancer is extremely poor in digestive cancers even with systemic therapy including surgery. Thus development of a new therapeutic approach is awaited. Recently, new trials of cancer treatments using monoclonal antibodies conjugated with anti-cancer drugs or labeled with isotopes have been reported. Here, we discuss the possible therapeutic application for pancreatic cancer of adriamycin-conjugated and 131I-labeled Nd2, which is produced against pancreatic cancer mucin.

Document emailed within 1 workday
Secure & encrypted payments

Kajiji, S.M.; Davceva, B.; Quaranta, V. 1987: Six monoclonal antibodies to human pancreatic cancer antigens Cancer Research 47(5): 1367-1376
Soares, M.; Nisol, F.; Bach, F.H.; Bazin, H.; Latinne, D. 1994: Use of anti-mu monoclonal antibody as a therapeutic approach to achieve depletion of xenoreactive natural antibodies Transplantation Proceedings 26(3): 1357-1359
Wagener, C.; Yang, Y.H.; Crawford, F.G.; Shively, J.E. 1983: Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies Journal of Immunology 130(5): 2308-2315
Ho, J.J.; Chung, Y.S.; Fujimoto, Y.; Bi, N.; Ryan, W.; Yuan, S.Z.; Byrd, J.C.; Kim, Y.S. 1988: Mucin-like antigens in a human pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1 Cancer Research 48(14): 3924-3931
Scheen, A.J.; Moutschen, M. 2009: Therapeutic monoclonal antibodies Revue Medicale de Liege 64(5-6): 233-236
Agius, M.A.; Geannopoulos, C.J.; Fairclough, R.H.; Richman, D.P. 1988: Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding Journal of Immunology 140(1): 62-68
Knapp, W.; Majdic, O.; Holter, W.; Stockinger, H.; Köller, U. 1985: Considerations on the therapeutic use of monoclonal antibodies Wiener Klinische Wochenschrift 97(3): 97-107
Okabe, T. 1989: New therapeutic methods with monoclonal antibodies Gan no Rinsho. Japan Journal of Cancer Clinics Spec No: 189-195
Grunow, R.; Volk, H.D.; von Baehr, R. 1985: Diagnostic and therapeutic use of monoclonal antibodies Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(18): 529-531
James, K. 1990: Human monoclonal antibodies and engineered antibodies in the management of cancer Seminars in Cancer Biology 1(3): 243-253
Kornbrot, B.; Kobayashi, R.H.; Singer, A.; Tempero, M.A.; Heiner, D.C. 1994: Hypersensitivity to therapeutic murine monoclonal antibodies Nebraska Medical Journal 79(12): 393-398
Walter, G.; Grün, K.; Siebert, M.; Bausch, S.; Gassmann, S.; Löchel, B.; Kreider, R.; Blackwood, J.; Inbar, S. 1990: Development of monoclonal antibodies for therapeutic drug monitoring Behring Institute Mitteilungen 86: 208-214
Goldsmith, S.J.; Signore, A. 2010: An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 54(6): 574-581
Emanuel, D.; Peppard, J.; Chehimi, J.; Hammerling, U.; O'Reilly, R. 1987: The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus Transplantation Proceedings 19(6 Suppl 7: 132-137
Tze, W.J.; Cheung, S.S.; Tai, J. 1992: Development of monoclonal and polyclonal anti-pancreatic cell antibodies for purification and identification of porcine islet cells Transplantation Proceedings 24(6): 2837-2839
Cavallini, M.; La Torre, M.; Citone, M.; Rossi, M.; Rebonato, A.; Nava, A.K.; Ferrari, L.; Salvi, P.F.; Ziparo, V. 2010: A novel approach in surgical palliation for unresectable pancreatic cancer with untreatable chronic pain: radiofrequency ablation of pancreatic mass and celiac plexus American Surgeon 76(8): E108-E109
Hanai, N.; Furuya, A.; Shitara, K.; Oda, S.; Yoshida, H. 1988: Comparative studies on monoclonal antibodies raised against human gastric cancer for application to serum diagnosis of cancer Anticancer Research 8(3): 329-334
Bosslet, K.; Schwarz, A.; Steinstraesser, A.; Kuhlmann, L.; Seidel, L.; Schulz, G. 1988: Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies Wiener Medizinische Wochenschrift 138(11-12): 255-257
Nakamura, R.; Saikawa, Y.; Hosokawa, S.; Fukuda, K.; Kumai, K.; Kubota, T.; Kitajima, M.; Kitagawa, Y. 2008: Development of 36 clones producing human monoclonal antibodies specific to cancer cells and their ability to inhibit cancer cell growth Anticancer Research 28(3a): 1651-1657
Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120